OFIX - Orthofix Medical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
51.14
-0.70 (-1.35%)
As of 2:53PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close51.84
Open51.98
Bid51.31 x 800
Ask51.41 x 1200
Day's Range51.09 - 52.26
52 Week Range47.79 - 74.44
Volume31,593
Avg. Volume137,687
Market Cap975.086M
Beta (3Y Monthly)0.53
PE Ratio (TTM)102.48
EPS (TTM)0.50
Earnings DateAug 6, 2018 - Aug 10, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est71.92
Trade prices are not sourced from all markets
  • Orthofix Medical Inc (OFIX) Q1 2019 Earnings Call Transcript
    Motley Fool15 days ago

    Orthofix Medical Inc (OFIX) Q1 2019 Earnings Call Transcript

    OFIX earnings call for the period ending March 31, 2019.

  • Orthofix (OFIX) Misses Q1 Earnings and Revenue Estimates
    Zacks15 days ago

    Orthofix (OFIX) Misses Q1 Earnings and Revenue Estimates

    Orthofix (OFIX) delivered earnings and revenue surprises of -32.50% and -1.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press15 days ago

    Orthofix: 1Q Earnings Snapshot

    The Lewisville, Texas-based company said it had net income of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to 27 cents per share. The medical device maker posted revenue of ...

  • Business Wire15 days ago

    Orthofix Reports First Quarter 2019 Results

    LEWISVILLE, Texas-- -- Net sales of $109.1 million, an increase of 0.4% compared to prior year and 1.9% on a constant currency basis Biologics products net sales increased 16.6% excluding the contractual reduction in marketing services fee Net income of $0.9 million; compared to net income of $5.2 million in the prior year Adjusted EBITDA of $15.7 million; a decrease of $4.1 million, or 20.5%, compared ...

  • ACCESSWIRE15 days ago

    Orthofix Medical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 6, 2019 / Orthofix Medical, Inc. (NASDAQ: OFIX ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 6, 2019 at 4:30 PM Eastern ...

  • Here’s What Hedge Funds Think About Orthofix Medical Inc. (OFIX)
    Insider Monkey18 days ago

    Here’s What Hedge Funds Think About Orthofix Medical Inc. (OFIX)

    After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of December 31. The results of that effort will be put on display in this article, as […]

  • Orthofix Medical Inc. (NASDAQ:OFIX): What Are The Future Prospects?
    Simply Wall St.19 days ago

    Orthofix Medical Inc. (NASDAQ:OFIX): What Are The Future Prospects?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Orthofix Medical Inc.'s (NASDAQ:OFIX) latest earnings announcement in December 2018 confirmed...

  • Business Wire22 days ago

    Orthofix Schedules First Quarter 2019 Earnings Release and Conference Call for May 6, 2019

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the first quarter 2019 after market close on Monday, May 6, 2019. Brad Mason, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 3049899.

  • Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration
    Business Wire28 days ago

    Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the first commercial implants of patients with the M6-C™ artificial cervical disc. The Center for Disc Replacement at Texas Back Institute (TBI) in Dallas, Texas recently implanted four patients suffering from single level cervical disc degeneration with the newly approved M6-C disc -- a next-generation artificial disc developed to replace an intervertebral disc damaged by cervical disc degeneration. Designed with an artificial viscoelastic nucleus and fiber annulus that mimics the anatomic structure of a natural disc, the M6-C device is the only artificial cervical disc available in the U.S. that enables compression or “shock absorption” at the implanted level.

  • A Closer Look At Orthofix Medical Inc.'s (NASDAQ:OFIX) Uninspiring ROE
    Simply Wall St.last month

    A Closer Look At Orthofix Medical Inc.'s (NASDAQ:OFIX) Uninspiring ROE

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for th...

  • Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results
    Zackslast month

    Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results

    The primary goal of the study was to assess the safety and efficacy of Orthofix's (OFX) M6-C artificial cervical disc in comparison to ACDF treatment.

  • Full Two-Year Data from Orthofix M6-C Artificial Cervical Disc Study Shows Significant Improvement in Pain, Function and Quality of Life Scores
    Business Wire2 months ago

    Full Two-Year Data from Orthofix M6-C Artificial Cervical Disc Study Shows Significant Improvement in Pain, Function and Quality of Life Scores

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the full two-year outcomes from its U.S. Investigational Device Exemption (IDE) study of the M6-C™ artificial cervical disc. Dr. Jack Zigler, orthopedic spine surgeon at Texas Back Institute and an investigator in the study, presented the study results during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in Anaheim, California. The data demonstrates that patients treated with the M6-C artificial cervical disc had significant improvements in neck and arm pain, function and quality of life scores.

  • Can You Imagine How Chuffed Orthofix Medical’s (NASDAQ:OFIX) Shareholders Feel About Its 123% Share Price Gain?
    Simply Wall St.2 months ago

    Can You Imagine How Chuffed Orthofix Medical’s (NASDAQ:OFIX) Shareholders Feel About Its 123% Share Price Gain?

    It might be of some concern to shareholders to see the Orthofix Medical Inc. (NASDAQ:OFIX) share price down 11% in the last month. But that doesn't change the fact thatRead More...

  • Orthofix Shares Waylaid by Margin Squeeze, Disappointing Outlook for 2019
    GuruFocus.com2 months ago

    Orthofix Shares Waylaid by Margin Squeeze, Disappointing Outlook for 2019

    FDA approval of a key addition to the Orthofix (NASDAQ: OFIX) line of cervical spine products wasn't enough to offset investor concerns about a gross margin squeeze when the company reported fourth quarter and full year results at the end of February. Warning! GuruFocus has detected 4 Warning Signs with TSLA. Perhaps the beat down may have been worse if the company hadn't earlier announced approval of the M6-C artificial cervical disc for patients suffering from cervical disc degeneration.

  • Orthofix (OFIX) Earnings Beat Estimates in Q4, Margins Fall
    Zacks3 months ago

    Orthofix (OFIX) Earnings Beat Estimates in Q4, Margins Fall

    Orthofix (OFIX) revenues across majority product lines witness year-over-year growth.

  • Benzinga3 months ago

    BTIG Downgrades Orthofix Medical On M6 Uncertainty

    Orthofix Medical Inc (NASDAQ: OFIX ) reported quarterly results Monday that were broadly in-line with expectations while guiding to higher spending and linear revenue growth. Investors can look past the ...

  • Orthofix International NV (OFIX) Q4 2018 Earnings Conference Call Transcript
    Motley Fool3 months ago

    Orthofix International NV (OFIX) Q4 2018 Earnings Conference Call Transcript

    OFIX earnings call for the period ending December 31, 2018.

  • ACCESSWIRE3 months ago

    Orthofix International NV to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 25, 2019 / Orthofix International NV (NASDAQ: OFIX ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 25, 2019 ...

  • Orthofix Medical Inc. (NASDAQ:OFIX) Has Attractive Fundamentals
    Simply Wall St.3 months ago

    Orthofix Medical Inc. (NASDAQ:OFIX) Has Attractive Fundamentals

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Orthofix Medical Inc. (NASDAQ:OFIX) is a stock with outstanding fundamentalRead More...

  • Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
    Zacks3 months ago

    Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

    Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Orthofix Announces FDA Approval of the M6-C Artificial Cervical Disc to Treat Patients with Cervical Disc Degeneration
    Business Wire3 months ago

    Orthofix Announces FDA Approval of the M6-C Artificial Cervical Disc to Treat Patients with Cervical Disc Degeneration

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced U.S. Food and Drug Administration (FDA) approval of the M6-C™ artificial cervical disc for patients suffering from cervical disc degeneration. The M6-C artificial cervical disc was developed by Spinal Kinetics, a company acquired by Orthofix in April 2018. “With the approval of the M6-C artificial cervical disc, Orthofix now has the industry’s most comprehensive portfolio of cervical spine products to best serve our surgeon customers and patients,” said Orthofix President and Chief Executive Officer, Brad Mason.

  • Business Wire3 months ago

    Orthofix Schedules Fourth Quarter and Fiscal 2018 Earnings Release and Conference Call for February 25, 2019

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the fourth quarter and fiscal 2018 after market close on Monday, February 25, 2019. Brad Mason, Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 7446347.

  • Business Wire4 months ago

    Orthofix Acquires Options Medical

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it has acquired the business of Options Medical, LLC, a medical device distributor based in Florida. Under the terms of the agreement, employees of Options Medical became employees of Orthofix effective February 1, 2019. “Options Medical started in North Central Florida as a small team of hard working individuals who wanted to provide the best in medical device solutions to physicians,” said Beth Stevenson, Distributor Principal and founder of Options Medical.

  • Read This Before Selling Orthofix Medical Inc. (NASDAQ:OFIX) Shares
    Simply Wall St.4 months ago

    Read This Before Selling Orthofix Medical Inc. (NASDAQ:OFIX) Shares

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...